• support@madhedgefundtrader.com
  • Member Login
Mad Hedge Fund Trader
  • Home
  • About
  • Store
  • Luncheons
  • Testimonials
  • Contact Us
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
MHFTR

The IRS Letter You Should Dread

Diary, Homepage Posts, Newsletter

With wait times for the IRS customer support line recently having extended from one hour to five hours, I thought conditions couldn’t get any worse.

I was wrong.

I knew the letter from the IRS sitting in my mailbox was bad news just from the color of the paper.

It was not light green, the color of a refund check from the United States Treasury.  Instead, it was white, warning that it contained some sort of demand, audit notice, or threatened legal action.

In fact, it was far worse than that.

In the most stilted, bureaucratic language possible, I was informed that my $100,000 tax refund for 2016 had already been paid out to someone else.

Another party using my name and social security number, but a different address, had already filed a 2016 return for me.

In order to get my money back, I would have to file a new return and include hard copies of every single piece of supporting documentation. It was, in effect, a full paper audit. Then I would have to wait 60 days.

This was three months ago.

I informed my accountant immediately. I heard him shout across the room to his partner, “Hey Joe, I’ve got another one.”

He told me that half of his clients had their refund checks stolen this year, and as a result, the IRS was now demanding automatic audits on all refund requests of four figures or more.

It gets worse. Budget cuts at the despised government agency mean that huge delays are occurring in almost all interactions. Even routine requests can sit on a bureaucrat’s desk for two years. The number of standard audits has fallen substantially.

The ones that take place are just a quick pass over, often conducted by mail, rather than the in-person, full proctologic examinations of the past.

Furthermore, the government didn’t have the money to pay for the latest upgrade of QuickBooks Pro.

This means it is unable to use the online accounting service’s spreadsheets during audits when the taxpayer’s accountant has upgraded, greatly increasing the time required for each audit while decreasing its effectiveness.

As a result, QuickBooks is seeing the fastest and most widespread adoption of its latest software version in history.

You can’t make this stuff up.

I asked my accountant how long it would really take for me to collect my 2016 refund.” Better count on a year,” he said.

Then the news flash came out that a hacker had stolen the tax returns of 100,000 individuals, including their personal information. I was one of those victims.

Not only did the crooks discover my name and social security number, they also knew that my high school team name was the “Apaches,” my first car was a “Volkswagen,” and that I was married in “Tokyo.”

I bet they know my inside leg measurement as well (I’m not telling!).

It all reminds me that it is once again time to revisit Palo Alto Networks (PANW). I have been recommending this cybersecurity name for the past three years, issuing Trade Alerts on each opportunistic dip.

The near destruction of Sony (SNE) by North Korean hackers has certainly put the fear of God into corporate America.

Apparently, they have no sense of humor whatsoever north of the 38th parallel.

I saw The Interview the other day on a plane, the film making fun of Supreme Leader Kim Jong-un that so pissed them off, and it totally sucked.

As a result, there is a generational upgrade in cybersecurity underway, with many potential targets boosting spending by multiples.

It’s not often that I get a stock recommendation from an army general. That is exactly what happened the other day when I was speaking to a three-star about the long-term implications of the Iran peace deal.

He argued persuasively that the world will probably never again see large-scale armies fielded by major industrial nations. Wars of the future will be fought online, as they have been silently and invisibly over the past 15 years.

All of those trillions of dollars spent on big-ticket, heavy-metal weapons systems are pure pork designed by politicians to buy voters in marginal swing states.

The money would be far better spent where it is most needed, on the cyber warfare front. Needless to say, my friend shall remain anonymous.

The problem is that when wars become cheaper, you fight more of them, as is the case with online combat. Cyber wars are now happening every day, all the time, 24/7, and everywhere.

You probably don’t know this, but during the Bush administration, the Chinese military downloaded the entire contents of the Pentagon’s mainframe computers at least seven times.

This was a neat trick because these computers were in stand-alone, siloed, electromagnetically shielded facilities not connected to the Internet in any way.

In the process, they obtained the designs of all of our most advanced weapons systems, including our best nukes. What have they done with this top-secret information?

Absolutely nothing.

Like many in senior levels of the US military, the Chinese have concluded that nuclear weapons are a useless waste of valuable resources.

Far better value for money is more hackers, coders, and servers, which the Chinese have pursued with a vengeance.

You have seen this in the substantial tightening up of the Chinese Internet through the deployment of the Great Firewall, which blocks local access to most foreign websites.

Some Mad Hedge Fund Trader subscribers in the Middle Kingdom have told me they can no longer access their US based online brokerage accounts, which are blocked by mainland “porn” filters.

“Porn” is defined as anything the Chinese government doesn’t agree with.

Try sending an email to someone in the Middle Kingdom with a Gmail address. It is almost impossible. This is why Google (GOOG) closed its offices five years ago.

As a member of the Joint Chiefs of Staff recently told me, “The greatest threat to national defense is wasting money on national defense.”

Although my brass-hatted friend didn’t mention the company by name, the implication is that I need to go out and buy Palo Alto Networks (PANW) right now.

Palo Alto Networks, Inc. is an American network security company based in Santa Clara, California, just across the water from my Bay Area office.

The company’s core products are advanced firewalls designed to provide network security, visibility, and granular control of network activity based on application, user, and content identification.

Palo Alto Networks competes in the unified threat management and network security industry against Cisco (CSCO), FireEye (FEYE), Fortinet (FTNT), Check Point (CHKP), Juniper Networks (JNPR), and Cyberoam, among others.

The really interesting thing about this industry is that there are no losers.

That’s because companies are taking a layered approach to cybersecurity, parceling out contracts to many of the leading firms at once, looking to hedge their bets.

To say that top management has no idea what these products really do would be a huge understatement. Therefore, they buy all of them.

This makes a basket approach to the industry more feasible than usual.

You can do this by buying the $0.70 million capitalized PureFunds ISE Cyber Security ETF (HACK), which boasts CyberArk Software (CYBR) and Infoblox (BLOX) as its three largest positions. (HACK) has been a hedge fund favorite since the Sony attack.

As for my tax refund, I am still waiting.

 

 

 

I Have Some Bad News for you, Mr. Thomas

https://www.madhedgefundtrader.com/wp-content/uploads/2015/05/IRS-Investigator.jpg 316 359 MHFTR https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png MHFTR2025-04-16 09:04:452025-04-16 13:42:39The IRS Letter You Should Dread
MHFTR

Testimonial

Diary, Homepage Posts, Newsletter, Testimonials

Just a quick note of appreciation for your helping me decide to get my clients into (GLD) with a 15% allocation early this year.

It sure has helped me to be more of a hero to my clients this year than a goat...

Best wishes to you and yours! Keep 'em coming.

Brad
Bakersfield, CA.

 

 

https://www.madhedgefundtrader.com/wp-content/uploads/2018/03/STORY-3-IMAGE-1-e1521930920192.jpg 300 400 MHFTR https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png MHFTR2025-04-16 09:02:112025-04-16 13:42:22Testimonial
april@madhedgefundtrader.com

April 16, 2025 - Quote of the Day

Diary, Newsletter, Quote of the Day

https://www.madhedgefundtrader.com/wp-content/uploads/2025/04/China-retaliates.png 924 1118 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-16 09:00:482025-04-16 13:42:11April 16, 2025 - Quote of the Day
april@madhedgefundtrader.com

Trade Alert - (NFLX) April 17, 2025 - EXPIRATION AT MAX PROFIT

Trade Alert

When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline. Read more

https://www.madhedgefundtrader.com/wp-content/uploads/2016/02/Alert-e1457452190575.jpg 135 150 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-15 13:12:572025-04-15 13:12:57Trade Alert - (NFLX) April 17, 2025 - EXPIRATION AT MAX PROFIT
april@madhedgefundtrader.com

April 15, 2025

Biotech Letter

Mad Hedge Biotech and Healthcare Letter
April 15, 2025
Fiat Lux

 

Featured Trade:

(THE WEIGHT OF EXPECTATIONS)

(LLY), (NVO)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-15 12:02:312025-04-15 12:12:40April 15, 2025
april@madhedgefundtrader.com

The Weight Of Expectations

Biotech Letter

You know that feeling when you've found the perfect restaurant? The food is exquisite, the atmosphere divine, and then you get the bill—and suddenly you're calculating if selling a kidney is a viable financial strategy.

That's essentially my relationship with Eli Lilly (LLY) right now. Phenomenal company, stellar performance, price tag that makes my wallet weep.

I've had a complicated romance with this pharmaceutical juggernaut. Back in my hedge fund days, I learned that timing is everything with pharma stocks. It's like catching the perfect wave off Malibu – ride it too early, you're just splashing in the shallows; too late, and you're eating sand.

When I first spotted Lilly in June 2023, it was set up beautifully. Shares rocketed 56.2% before I downgraded to a 'hold' last February, while the broader market trudged along with a mere 12.3% gain.

Since then, the stock has performed almost exactly as predicted—just a 0.2% gain compared to the S&P 500's 1.33%. More recently, it's dropped 6.9% since January, looking positively rosy next to the broader market's 12.2% decline.

The company's fourth-quarter results read like a biotech investor's fantasy novel. Revenue soared 44.7% year-over-year to $13.53 billion, driven by its dynamic weight-loss duo.

Mounjaro's sales jumped 60.1% to $3.53 billion, while Zepbound exploded from $175.8 million to a jaw-dropping $1.91 billion.

I've watched patients in clinical trials shed substantial weight on these medications—one of my research contacts dropped 43.4 pounds since starting treatment—and I can tell you these drugs are creating waves not just in waistlines but across the entire healthcare sector.

Other stars in Lilly's portfolio include Verzenio for breast cancer (up to $1.56 billion from $1.15 billion), Jardiance for diabetes (climbing to $1.20 billion), and solid gains from Taltz and Humalog.

Only Trulicity disappointed, watching its revenue tumble from $1.67 billion to $1.25 billion—predictably cannibalized by Lilly's newer weight-loss offerings. It's like watching your reliable sedan gathering dust after buying a Tesla.

With this revenue bonanza, profits naturally skyrocketed. Net income more than doubled to $4.41 billion, adjusted profits surged to $4.81 billion, and operating cash flow swung from negative $311.9 million to positive $2.47 billion.

In my decades of following pharmaceutical stocks from Tokyo to Wall Street, I've rarely seen a quarterly performance this impressive. If Lilly were a student, it would be the annoying one breaking the curve for everyone else.

Looking ahead, management projects 2025 revenue between $58-61 billion (a 32.1% increase at midpoint) and adjusted EPS between $22.50-24.

For the upcoming Q1 report on May 1st, analysts anticipate revenue of $12.77 billion (45.6% higher year-over-year) and EPS of $4.70 (nearly double last year's $2.48).

So with all this financial wizardry, why maintain a 'hold'? One word: valuation.

Even using 2025's projected figures, Lilly trades at eye-watering multiples: forward P/E of 33.3, price-to-cash-flow of 27.6, and EV/EBITDA of 21.2.

For context, pharmaceutical peers trade significantly lower. Novo Nordisk (NVO), perhaps the most comparable given its similar weight-loss market success, trades at a P/E of 19.0, price-to-cash-flow of 15.9, and EV/EBITDA of 14.6.

It's like comparing Manhattan real estate to Cleveland—both might be perfectly fine places to live, but one demands a significant premium.

Don't mistake my caution for bearishness. Lilly's product pipeline is robust, highlighted by Retatrutide, which has shown even more impressive weight-loss results—patients lost an average of 24.2% of their body weight (58 pounds) in clinical trials.

The company is also expanding its manufacturing footprint with four new US sites, creating 3,000 permanent jobs. It's acquiring promising treatments like Scorpion Therapeutics' STX-478 for $2.5 billion upfront.

Meanwhile, shareholders enjoyed $4.7 billion in dividends and $2.5 billion in buybacks last year, with a new $15 billion repurchase program and a 15% dividend increase announced for 2025.

I'd compare Lilly's stock to its own weight-loss drugs: remarkably effective, potentially life-changing, but priced at a level that makes you question whether the benefits justify the cost.

If May's results blast past expectations with raised guidance, I'll happily reconsider. Until then, I'm maintaining my 'hold'—admiring from across the room, but not ready to propose just yet.

 

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-15 12:00:042025-04-15 12:07:38The Weight Of Expectations
april@madhedgefundtrader.com

April 15, 2025

Diary, Newsletter, Summary

Global Market Comments
April 15, 2025
Fiat Lux

 

Featured Trade:

(HOW TO HANDLE THE THURSDAY, APRIL 17 OPTIONS EXPIRATION)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-15 09:04:112025-04-15 10:02:56April 15, 2025
april@madhedgefundtrader.com

How to Handle the Thursday, April 17 Options Expiration

Diary, Homepage Posts, Newsletter

Followers of the Mad Hedge Fund Trader alert service have the good fortune to own FIVE in-the-money options positions that expire on Thursday, April 17, and I just want to explain to the newbies how to best maximize their profits.

These involve the:

 

Risk On

(COST) 4/$840-$850 call spread         10.00%

(TSLA) 4/$160/$170 put spread           10.00%

(NFLX) 4/$800-$810 call spread         10.00%

(NVDA) 4/$70-$75 call spread              10.00%

 

Risk Off

(MSTR) 4/$340-$350 put spread         -10.00%

 

Provided that we don’t have a monster move in the market in three trading days, these positions should expire at their maximum profit points.

So far, so good.

I’ll take the example of the (NVDA) 4/$70-$75 call spread.

Your profit can be calculated as follows:

Profit: $5.00 expiration value - $4.50 cost = $0.50 net profit

(25 contracts X 100 contracts per option X $0.50 profit per option)

= $1,250 or 11.11% in 9 trading days.

Many of you have already emailed me asking what to do with these winning positions.

The answer is very simple. You take your left hand, grab your right wrist, pull it behind your neck, and pat yourself on the back for a job well done.

You don’t have to do anything.

Your broker (are they still called that?) will automatically use your long position to cover your short position, canceling out the total holdings.

The entire profit will be credited to your account on Monday morning, April 21, and the margin freed up.

Some firms charge you a modest $10 or $15 fee for performing this service.

If you don’t see the cash show up in your account on Monday, get on the blower immediately and find it.

Although the expiration process is now supposed to be fully automated, occasionally, machines do make mistakes. Better to sort out any confusion before losses ensue.

If you want to wimp out and close the position before the expiration, it may be expensive to do so. You can probably unload those pennies below their maximum expiration value.

Keep in mind that the liquidity in the options market understandably disappears and the spreads substantially widen when a security has only hours or minutes until expiration on Thursday. So, if you plan to exit, do so well before the final expiration at the Thursday market close.

This is known in the trade as the “expiration risk.”

One way or the other, I’m sure you’ll do OK, as long as I am looking over your shoulder, as I will always. Think of me as your trading guardian angel.

I am going to hang back and wait for good entry points before jumping back in. It’s all about keeping that “Buy low, sell high” thing going.

I’m looking to cherry-pick my new positions going into the next quarter's end.

Take your winnings and go out and buy yourself a well-earned dinner.

Well done, and on to the next trade.

 

You Can’t Do Enough Research

https://www.madhedgefundtrader.com/wp-content/uploads/2019/09/john-and-girls.png 322 345 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-15 09:02:192025-04-15 10:02:38How to Handle the Thursday, April 17 Options Expiration
Douglas Davenport

OPENAI'S CASH BURN PARADOX

Mad Hedge AI

(NVDA), (MSFT), (GOOG),(AMZN)

You know what's crazy? A company that burns $5 billion a year in computing costs getting valued at $300 billion.

Yet here we are. OpenAI just closed a monster funding round, raising up to $40 billion from investors including SoftBank Group at a staggering $300 billion valuation. That's nearly double what the company was valued at just six months ago.

I've seen this movie before, both as a hedge fund manager and while dodging Russian artillery in Ukraine. Euphoria rarely ends well, whether in markets or on battlefields.

The company behind ChatGPT has become the darling of the investment world despite the fact that it won't be profitable until 2029, according to Sam Altman's own projections. 2029! That's four years and several AI generations from now.

This is a company that expects to generate $13 billion in revenue this year, which sounds impressive until you realize they'll likely spend more than that on computing costs alone. In fact, in 2024, OpenAI reported revenue of around $4 billion while racking up $5 billion in computing costs just to train and run their models.

When I was running hedge funds in the 1990s, we had a technical term for businesses like this: money pits.

Let's dive deeper into these numbers. Over 90% of OpenAI's 500 million users worldwide pay absolutely nothing to use the service. In 2025, the company projects that just under 5% of users might pay the $20-a-month charge to access their more advanced AI models. That would generate about $5.5 billion. Another 0.3% might opt for ChatGPT Pro, contributing another $3.6 billion.

The trouble is that a whopping 70% of OpenAI's revenue comes with expenses that may keep rising faster than the top line. According to reporting from The Information, by the end of the decade, OpenAI will still probably spend 60% to 80% of its annual revenue just to train or run its models.

Meanwhile, competition is heating up. OpenAI's market share of enterprise large language models (LLMs) has already fallen to 34% in 2024 from 50% a year ago, according to Menlo Ventures data. Companies like Anthropic, Meta, Google, and Mistral AI are eating into their lead.

And there's another problem: intense pricing competition. As companies like Mistral AI and Anthropic offer competitive alternatives, OpenAI's ability to charge premium prices for its API services is under pressure.

During my decades reporting from Asia, I witnessed countless companies with "revolutionary technology" that eventually became commoditized faster than anyone expected. When I covered the Japanese semiconductor industry in the 1970s, companies that once had seemingly unassailable leads saw their margins evaporate within years.

So why are investors like SoftBank's Masayoshi Son so eager to pour billions into this cash-burning machine? The answer lies in the potential of achieving artificial general intelligence (AGI) – AI systems that can perform any intellectual task that a human can. If OpenAI succeeds in developing AGI, the economic rewards could be incalculable.

In a fascinating twist, OpenAI just made its first cybersecurity investment, putting money into a startup called Cosmic. This signals a strategic expansion beyond its core AI development work. Smart move, considering that as AI becomes more ubiquitous, securing it becomes increasingly critical.

Additionally, there are rumors that OpenAI may release an open-source model, which would be a significant shift in strategy. This could be a play to expand their ecosystem and solidify their position as the standard-bearer in AI development.

For investors trying to play the AI revolution, the question becomes: is it better to invest directly in pure AI plays like OpenAI (if and when it goes public), or in the companies that actually make money from the AI boom today?

The smartest money might be in NVIDIA (NVDA), which supplies the crucial GPUs that power AI development. Despite trading at seemingly high multiples, NVIDIA continues to see explosive growth in data center revenue as AI development accelerates. Even with competition from AMD and Intel, NVIDIA maintains a commanding lead in AI chip technology.

Microsoft (MSFT) provides another interesting angle, given its deep partnership with OpenAI. The company has exclusive rights to commercialize OpenAI's technology and has already integrated ChatGPT capabilities across its product line, from Bing to Office 365.

For those looking at pure AI plays beyond the giants, Anthropic (backed by Google (GOOG) and Amazon (AMZN)) and Mistral AI represent interesting alternatives to OpenAI, though they remain private for now.

Is AI revolutionary? Absolutely. Are most AI companies going to make money anytime soon? Don't bet your retirement on it. For OpenAI to hit Altman's projected $125 billion revenue target by 2029, they need to grow 10-fold while dramatically shifting from money-losing free users to enterprise clients that actually pay the bills.

That's a tall order, even for a company with seemingly unlimited access to capital. I've witnessed too many "guaranteed successes" implode over my five decades in the markets. After covering countless bubbles from Tokyo to Silicon Valley, I've learned that eventually, cash flow matters. Always.

If I were allocating capital today, I'd be putting my money on companies with proven ability to convert AI hype into actual profits. Let others chase the AGI dream while you count real returns.

At this late stage in my life, I've learned that what seems inevitable rarely is, and what looks impossible often becomes routine within years. Will OpenAI justify its $300 billion valuation? Perhaps. But at these prices, investors are paying for perfection when the company hasn't even figured out a sustainable business model.

That's not investing – that's speculation.

And if there's one thing my bullet wound from Ukraine taught me, it's that life's too short for bad bets.

https://www.madhedgefundtrader.com/wp-content/uploads/2025/04/Screenshot-2025-04-14-164159.png 495 492 Douglas Davenport https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png Douglas Davenport2025-04-14 16:43:042025-04-14 16:43:39OPENAI'S CASH BURN PARADOX
april@madhedgefundtrader.com

April 14, 2025

Tech Letter

Mad Hedge Technology Letter
April 14, 2025
Fiat Lux

 

Featured Trade:

(BIG TECH ANXIOUS FOR CLARITY)
(MSFT), (AAPL), ($COMPQ)

https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png 0 0 april@madhedgefundtrader.com https://madhedgefundtrader.com/wp-content/uploads/2019/05/cropped-mad-hedge-logo-transparent-192x192_f9578834168ba24df3eb53916a12c882.png april@madhedgefundtrader.com2025-04-14 14:04:232025-04-14 16:00:53April 14, 2025
Page 9 of 16«‹7891011›»

tastytrade, Inc. (“tastytrade”) has entered into a Marketing Agreement with Mad Hedge Fund Trader (“Marketing Agent”) whereby tastytrade pays compensation to Marketing Agent to recommend tastytrade’s brokerage services. The existence of this Marketing Agreement should not be deemed as an endorsement or recommendation of Marketing Agent by tastytrade and/or any of its affiliated companies. Neither tastytrade nor any of its affiliated companies is responsible for the privacy practices of Marketing Agent or this website. tastytrade does not warrant the accuracy or content of the products or services offered by Marketing Agent or this website. Marketing Agent is independent and is not an affiliate of tastytrade. 

Legal Disclaimer

There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Copyright © 2025. Mad Hedge Fund Trader. All Rights Reserved. support@madhedgefundtrader.com
Scroll to top